Cohen H - Search Results

1

Should all diabetic patients be treated with a statin?

Kamari Y, Bitzur R, Cohen H, Shaish A, Harats D. Kamari Y, et al. Among authors: cohen h. Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S378-83. doi: 10.2337/dc09-S344. Diabetes Care. 2009. PMID: 19875585 Free PMC article. Review. No abstract available.

2

Mechanisms of action of the anti-atherogenic effect of magnesium: lessons from a mouse model.

Sherer Y, Bitzur R, Cohen H, Shaish A, Varon D, Shoenfeld Y, Harats D. Sherer Y, et al. Among authors: cohen h. Magnes Res. 2001 Sep;14(3):173-9. Magnes Res. 2001. PMID: 11599549

3

Association between serum apolipoprotein C(II) concentration and coronary heart disease.

Gerber Y, Goldbourt U, Cohen H, Harats D. Gerber Y, et al. Among authors: cohen h. Prev Med. 2002 Jul;35(1):42-7. doi: 10.1006/pmed.2002.1045. Prev Med. 2002. PMID: 12079439

4

Diuretic induced hyponatraemia in elderly hypertensive women.

Sharabi Y, Illan R, Kamari Y, Cohen H, Nadler M, Messerli FH, Grossman E. Sharabi Y, et al. Among authors: cohen h. J Hum Hypertens. 2002 Sep;16(9):631-5. doi: 10.1038/sj.jhh.1001458. J Hum Hypertens. 2002. PMID: 12214259

5

Rosiglitazone (PPARgamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model.

Levi Z, Shaish A, Yacov N, Levkovitz H, Trestman S, Gerber Y, Cohen H, Dvir A, Rhachmani R, Ravid M, Harats D. Levi Z, et al. Among authors: cohen h. Diabetes Obes Metab. 2003 Jan;5(1):45-50. doi: 10.1046/j.1463-1326.2003.00240.x. Diabetes Obes Metab. 2003. PMID: 12542724

6

Atherogenesis inhibition induced by magnesium-chloride fortification of drinking water.

Cohen H, Sherer Y, Shaish A, Shoenfeld Y, Levkovitz H, Bitzur R, Harats D. Cohen H, et al. Biol Trace Elem Res. 2002 Winter;90(1-3):251-9. doi: 10.1385/BTER:90:1-3:251. Biol Trace Elem Res. 2002. PMID: 12666839

7

Omapatrilat, an angiotensin-converting enzyme and neutral endopeptidase inhibitor, attenuates early atherosclerosis in diabetic and in nondiabetic low-density lipoprotein receptor-deficient mice.

Levy Z, Dvir A, Shaish A, Trestman S, Cohen H, Levkovietz H, Rhachmani R, Ravid M, Harats D. Levy Z, et al. Among authors: cohen h. Int J Exp Diabesity Res. 2003 Jan-Mar;4(1):59-64. doi: 10.1080/15438600303728. Int J Exp Diabesity Res. 2003. PMID: 12745671 Free PMC article.

8

Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter.

Harats D, Ben-Shushan D, Cohen H, Gonen A, Barshack I, Goldberg I, Greenberger S, Hodish I, Harari A, Varda-Bloom N, Levanon K, Grossman E, Chaitidis P, Kühn H, Shaish A. Harats D, et al. Among authors: cohen h. Cancer Lett. 2005 Nov 8;229(1):127-34. doi: 10.1016/j.canlet.2005.02.017. Cancer Lett. 2005. PMID: 16157225

9

9-cis beta-carotene-rich powder of the alga Dunaliella bardawil increases plasma HDL-cholesterol in fibrate-treated patients.

Shaish A, Harari A, Hananshvili L, Cohen H, Bitzur R, Luvish T, Ulman E, Golan M, Ben-Amotz A, Gavish D, Rotstein Z, Harats D. Shaish A, et al. Among authors: cohen h. Atherosclerosis. 2006 Nov;189(1):215-21. doi: 10.1016/j.atherosclerosis.2005.12.004. Epub 2006 Jan 18. Atherosclerosis. 2006. PMID: 16413556 Clinical Trial.

10

Endothelin B receptor antagonist increases preproendothelin-1 transcription in bovine aortic endothelial cells and in vivo.

Peled M, Shaish A, Frishman L, Cohen H, Tal R, Harats D. Peled M, et al. Among authors: cohen h. J Cardiovasc Pharmacol. 2006 May;47(5):668-72. doi: 10.1097/01.fjc.0000211755.54691.ba. J Cardiovasc Pharmacol. 2006. PMID: 16775506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,911 results

Search Page

Filters